The COVID-19 Pandemic Highlights Opportunities to Improve Hepatocellular Carcinoma Screening and Diagnosis in a National Health System.
Nicole J KimKarine Rozenberg-Ben-DrorDavid A JacobKristin BerryGeorge N IoannouPublished in: The American journal of gastroenterology (2022)
Screening and diagnosis rates declined after the COVID-19 pandemic. Prioritizing screening for patients at greatest risk for HCC may reduce delays in diagnosis.
Keyphrases